Document | 2026/2027 Edition | 250 Verified Questions
DC DOH Clinical Laboratory Technician Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest DC DOH Guidelines | Graded A+
This comprehensive exam preparation document contains 250 verified questions and answers
meticulously aligned with the District of Columbia Department of Health (DC DOH) Clinical
Laboratory Technician licensure examination. Covering essential clinical laboratory science domains,
this resource is designed to reinforce knowledge and test-taking strategies. Each question includes
detailed rationales, ensuring a deep understanding of core concepts. Ideal for candidates seeking to
excel on the 2026/2027 academic year exam.
Abstract:
This document serves as a definitive study resource for the District of Columbia Clinical Laboratory Technician
(CLT) certification exam, reflecting the 2026/2027 academic year requirements. It comprises 250 verified
multiple-choice questions with correct answers and detailed rationales, systematically organized by clinical
laboratory disciplines such as hematology, clinical chemistry, microbiology, immunology, urinalysis, and
laboratory operations. Emphasis is placed on practical application of laboratory principles, quality assurance,
and regulatory compliance as mandated by the DC Department of Health. Each question is designed to assess both
recall and higher-order thinking, mimicking the actual exam format. Rationales explain not only why the correct
answer is right but also why distractors are incorrect, facilitating comprehensive learning. This material has been
updated to include recent advancements in diagnostic technologies and changes in local regulations, ensuring
users study the most current information. By mastering these questions, candidates can identify knowledge gaps,
improve test-taking speed, and approach the exam with confidence.
Content Area Overview:
Content Area Questions Key Topics Weight
Hematology and Hemostasis 1-50 CBC interpretation, coagulation factors, 20%
platelet function, anemias, bleeding
disorders
Clinical Chemistry 51-100 Metabolic panels, liver and renal function, 20%
cardiac markers, electrolytes, therapeutic
drug monitoring
Microbiology 101-150 Gram staining, culture methods, bacterial 20%
identification, antimicrobial susceptibility,
virology basics
Immunology and Serology 151-180 Immunoassay principles, infectious disease 12%
serology, autoimmune disease testing,
hypersensitivity
Urinalysis and Body Fluids 181-210 Urine dipstick, sediment microscopy, CSF 12%
analysis, other body fluids, renal disease
Laboratory Operations and 211-250 Quality control, safety regulations, 16%
Safety phlebotomy, specimen handling, CLIA/DC
DOH compliance
Page 1
,Q1. A complete blood count shows hemoglobin 7.2 g/dL, hematocrit 21%, RBC 2.8×10^6/L, and
reticulocyte count 0.2% (absolute reticulocyte count 5,600/L). Which of the following best
characterizes this anemia?
A. Hypoproliferative anemia due to bone marrow suppression
B. Hemolytic anemia with appropriate marrow response
C. Anemia of chronic disease with ineffective erythropoiesis
D. Iron deficiency anemia with early reticulocytosis
Correct Answer: A. Hypoproliferative anemia due to bone marrow suppression
Rationale: The absolute reticulocyte count (ARC) is 5,600/¼L, which is markedly low (normal
~25,000-75,000/L), indicating inadequate marrow production. This hypoproliferative anemia fits with
aplastic anemia or severe marrow damage. Hemolytic anemia would show elevated ARC. Anemia of
chronic disease usually has low but not extremely low ARC. Iron deficiency anemia typically has a low
reticulocyte count but not this low. The correct answer is A.
Why Wrong:
B - Hemolytic anemia would show elevated reticulocyte production, not such a low ARC.
C - Anemia of chronic disease usually has a low reticulocyte count, but ARC above 10,000/L is
more common; extreme low is more consistent with marrow failure.
D - Iron deficiency anemia classically shows low reticulocyte count, but ARC below 10,000/L is
rare; additionally, no microcytosis or hypochromia is mentioned.
Reference: Clinical Laboratory Hematology, 3rd ed., Ch. 8
Q2. A serum sample from a patient with chest pain shows an elevated total CK but normal CK-MB
relative index (<3%). Troponin I is negative. Which of the following is the most likely explanation?
A. Skeletal muscle injury due to recent intramuscular injection
B. Acute myocardial infarction with delayed troponin rise
C. Macro-CK type 1 interference falsely elevating total CK
D. Brain injury causing release of CK-BB
Correct Answer: A. Skeletal muscle injury due to recent intramuscular injection
Rationale: Elevated total CK with normal CK-MB relative index indicates that the elevated CK is mostly
from skeletal muscle (CK-MM). Subcellular injury from IM injections can cause CK release. Acute MI
would show elevated CM-MB. Macro-CK type 1 is a complex with IgG that often elevates CK-MB
fraction, not isolated total CK. CK-BB is negligible in serum. The correct answer is A.
Why Wrong:
B - Acute MI would typically have elevated CK-MB relative index and troponin; troponin negative
and low CK-MB makes MI unlikely.
C - Macro-CK type 1 typically elevates CK-MB, not total CK alone, and would increase CK-MB
relative index.
D - CK-BB from brain injury is rapidly cleared from serum and rarely causes significant total CK
elevation.
Reference: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th ed., Ch. 21
Page 2
,Q3. A wound culture grows Gram-positive cocci in clusters, catalase positive, coagulase negative.
The isolate is resistant to cefoxitin but susceptible to vancomycin. Which of the following is the most
accurate interpretation?
A. Staphylococcus aureus, MRSA, vancomycin susceptible
B. Staphylococcus epidermidis, MRSE, vancomycin susceptible
C. Streptococcus agalactiae, penicillin resistant
D. Enterococcus faecalis, VRE, linezolid susceptible
Correct Answer: B. Staphylococcus epidermidis, MRSE, vancomycin susceptible
Rationale: Gram-positive cocci in clusters, catalase positive, and coagulase negative identifies the
organism as a coagulase-negative staphylococcus (e.g., S. epidermidis). Cefoxitin resistance indicates
methicillin resistance (MRSE). Vancomycin is typically used for MRSE. Staphylococcus aureus is
coagulase positive. Streptococcus and Enterococcus are catalase negative. The correct answer is B.
Why Wrong:
A - S. aureus is coagulase-positive, not coagulase-negative.
C - Streptococci are catalase negative and appear in chains, not clusters.
D - Enterococci are catalase negative and are not Gram-positive cocci in clusters.
Reference: Manual of Clinical Microbiology, 12th ed., Ch. 15
Q4. A urinalysis reveals 3+ protein, 2+ blood, dysmorphic RBCs, and RBC casts. Which of the
following is the most likely diagnosis?
A. Renal calculi causing hematuria and proteinuria
B. Acute tubular necrosis with muddy brown casts
C. Glomerulonephritis with active sediment
D. Urinary tract infection with pyuria and bacteriuria
Correct Answer: C. Glomerulonephritis with active sediment
Rationale: Dysmorphic RBCs and RBC casts are hallmark findings of glomerular disease, specifically
glomerulonephritis. Proteinuria indicates glomerular injury. Renal calculi would not typically produce
dysmorphic RBCs or casts. ATN shows muddy brown granular casts, not RBC casts. UTI would show
white cells and bacteria. The correct answer is C.
Why Wrong:
A - Renal calculi cause hematuria but with eumorphic RBCs, not dysmorphic, and rarely proteinuria
of this degree.
B - Acute tubular necrosis typically presents with muddy brown granular casts, not RBC casts.
D - Urinary tract infection is characterized by pyuria, bacteriuria, and WBC casts, not RBC casts.
Reference: Urinalysis and Body Fluids, 7th ed., Ch. 6
Page 3
, Q5. A patient with blood type O, D-negative has a positive antibody screen. Panel cells show
reactivity with all cells except autologous control. The antibody is identified as anti-D. Which of the
following is the most appropriate interpretation?
A. The patient has anti-D from prior transfusion; type O D-negative units should be crossmatched
B. The patient has anti-D that is autoantibody; use D-negative units and consider autoimmune workup
C. The patient has anti-D from pregnancy; Rh immune globulin should be administered
D. The patient has a weakly reactive anti-D that is clinically insignificant
Correct Answer: A. The patient has anti-D from prior transfusion; type O D-negative units should
be crossmatched
Rationale: In an O D-negative patient, anti-D is an alloantibody, often from transfusion or pregnancy.
The antibody screen is positive and autologous control is negative (ruling out autoantibody). Therefore,
the patient requires D-negative RBC units. Rh immune globulin is not for treating existing anti-D; it is for
prevention. Weakly reactive anti-D is still clinically significant. The correct answer is A.
Why Wrong:
B - Autologous control is negative, ruling out autoimmune cause; anti-D in a D-negative person is
alloimmune.
C - Rh immune globulin is used to prevent alloimmunization, not to treat existing anti-D.
D - Anti-D is known to be clinically significant and can cause hemolytic transfusion reactions.
Reference: AABB Technical Manual, 20th ed., Ch. 12
Q6. A patient on warfarin for atrial fibrillation has an INR of 3.2. The aPTT is 44 seconds
(reference 25-35). Which of the following is the most accurate assessment?
A. Therapeutic INR; aPTT prolongation reflects warfarin effect on factor IX and X
B. Supratherapeutic INR; risk of bleeding; consider holding warfarin
C. INR within goal range; aPTT is artifactually prolonged due to heparin contamination
D. Subtherapeutic INR; aPTT elevation indicates coexisting factor deficiency
Correct Answer: A. Therapeutic INR; aPTT prolongation reflects warfarin effect on factor IX and
X
Rationale: A therapeutic INR for atrial fibrillation is typically 2.0–3.0; 3.2 is slightly above but still near
therapeutic range (some guidelines accept up to 3.5). Warfarin affects vitamin K-dependent factors II, VII,
IX, X, and proteins C and S. Factor IX deficiency can prolong aPTT, and factor X can also affect both PT
and aPTT. Therefore, mild aPTT prolongation is expected. Heparin contamination is not implied. The
aPTT is not artifactually prolonged; it reflects warfarin effect. Subtherapeutic INR would be below 2.0.
The correct answer is A.
Why Wrong:
B - INR 3.2 is slightly above the typical goal of 2.0-3.0 but not severely supratherapeutic; many
clinicians would not hold warfarin for this.
C - The aPTT prolongation is consistent with warfarin's effect on factors IX and X; heparin
contamination would cause more pronounced aPTT rise and possibly a prolonged TT.
D - An INR of 3.2 is above therapeutic range, not subtherapeutic.
Reference: Hemostasis and Thrombosis, 4th ed., Ch. 22
Page 4